

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of water loss via skin (GO:0033561) | 9.91048741 |
| 2 | desmosome organization (GO:0002934) | 8.01763872 |
| 3 | multicellular organismal water homeostasis (GO:0050891) | 6.93953960 |
| 4 | keratinization (GO:0031424) | 6.64998369 |
| 5 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.37093358 |
| 6 | intestinal epithelial cell development (GO:0060576) | 5.97784199 |
| 7 | water homeostasis (GO:0030104) | 5.56195339 |
| 8 | positive regulation of interleukin-8 secretion (GO:2000484) | 5.46244664 |
| 9 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.37275137 |
| 10 | detection of bacterium (GO:0016045) | 5.34063081 |
| 11 | regulation of transforming growth factor beta1 production (GO:0032908) | 5.26563108 |
| 12 | positive regulation of glomerulus development (GO:0090193) | 5.19638900 |
| 13 | keratinocyte differentiation (GO:0030216) | 4.99082969 |
| 14 | glycosphingolipid catabolic process (GO:0046479) | 4.93930149 |
| 15 | epidermal cell differentiation (GO:0009913) | 4.80163268 |
| 16 | keratinocyte proliferation (GO:0043616) | 4.72716246 |
| 17 | detection of other organism (GO:0098543) | 4.69119858 |
| 18 | * calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.68818880 |
| 19 | chemical homeostasis within a tissue (GO:0048875) | 4.66191071 |
| 20 | regulation of vitamin metabolic process (GO:0030656) | 4.58768441 |
| 21 | sphingoid metabolic process (GO:0046519) | 4.58051182 |
| 22 | oligosaccharide catabolic process (GO:0009313) | 4.55860311 |
| 23 | glycolipid catabolic process (GO:0019377) | 4.54937186 |
| 24 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.43194940 |
| 25 | hair cell differentiation (GO:0035315) | 4.41598821 |
| 26 | auditory receptor cell differentiation (GO:0042491) | 4.16279569 |
| 27 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.11438450 |
| 28 | surfactant homeostasis (GO:0043129) | 4.01972683 |
| 29 | diol metabolic process (GO:0034311) | 3.99716466 |
| 30 | regulation of mononuclear cell migration (GO:0071675) | 3.99385845 |
| 31 | regulation of interleukin-8 secretion (GO:2000482) | 3.95561070 |
| 32 | regulation of chemokine secretion (GO:0090196) | 3.94807616 |
| 33 | ceramide catabolic process (GO:0046514) | 3.94659102 |
| 34 | eosinophil chemotaxis (GO:0048245) | 3.94066112 |
| 35 | angiotensin maturation (GO:0002003) | 3.92000414 |
| 36 | membrane lipid catabolic process (GO:0046466) | 3.79826876 |
| 37 | virion attachment to host cell (GO:0019062) | 3.75246980 |
| 38 | adhesion of symbiont to host cell (GO:0044650) | 3.75246980 |
| 39 | sphingolipid catabolic process (GO:0030149) | 3.72750516 |
| 40 | keratinocyte development (GO:0003334) | 3.72090136 |
| 41 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.69273172 |
| 42 | antibacterial humoral response (GO:0019731) | 3.66178666 |
| 43 | sphingosine metabolic process (GO:0006670) | 3.65666524 |
| 44 | regulation of glomerulus development (GO:0090192) | 3.65085284 |
| 45 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.64483811 |
| 46 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.60921643 |
| 47 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.60921643 |
| 48 | interferon-gamma secretion (GO:0072643) | 3.59270319 |
| 49 | glandular epithelial cell differentiation (GO:0002067) | 3.59058085 |
| 50 | inner ear receptor cell differentiation (GO:0060113) | 3.58221476 |
| 51 | hormone catabolic process (GO:0042447) | 3.56832567 |
| 52 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.54720743 |
| 53 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.47653113 |
| 54 | regulation of ruffle assembly (GO:1900027) | 3.46202263 |
| 55 | eosinophil migration (GO:0072677) | 3.45823589 |
| 56 | skin morphogenesis (GO:0043589) | 3.45782778 |
| 57 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.44918422 |
| 58 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.44495955 |
| 59 | epoxygenase P450 pathway (GO:0019373) | 3.42967896 |
| 60 | amyloid precursor protein catabolic process (GO:0042987) | 3.36969897 |
| 61 | antimicrobial humoral response (GO:0019730) | 3.36725278 |
| 62 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.34552692 |
| 63 | phospholipid efflux (GO:0033700) | 3.34319482 |
| 64 | lung secretory cell differentiation (GO:0061140) | 3.32674463 |
| 65 | peptide catabolic process (GO:0043171) | 3.29382112 |
| 66 | transepithelial transport (GO:0070633) | 3.27166573 |
| 67 | adhesion of symbiont to host (GO:0044406) | 3.26312209 |
| 68 | ectoderm development (GO:0007398) | 3.25084335 |
| 69 | transcytosis (GO:0045056) | 3.24055206 |
| 70 | negative regulation of cell fate commitment (GO:0010454) | 3.23507818 |
| 71 | ethanol oxidation (GO:0006069) | 3.21915930 |
| 72 | epidermis development (GO:0008544) | 3.20643186 |
| 73 | barbed-end actin filament capping (GO:0051016) | 3.19768811 |
| 74 | regulation of chromatin binding (GO:0035561) | 3.19163199 |
| 75 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.18865304 |
| 76 | phosphatidylserine metabolic process (GO:0006658) | 3.18454438 |
| 77 | hemidesmosome assembly (GO:0031581) | 3.16960251 |
| 78 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.16836856 |
| 79 | peptide cross-linking (GO:0018149) | 3.16764363 |
| 80 | regulation of guanylate cyclase activity (GO:0031282) | 3.16104693 |
| 81 | eyelid development in camera-type eye (GO:0061029) | 3.14671567 |
| 82 | hepatocyte apoptotic process (GO:0097284) | 3.13051074 |
| 83 | phospholipid scrambling (GO:0017121) | 3.12669824 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.12601500 |
| 85 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.09096773 |
| 86 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.07958682 |
| 87 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.07201235 |
| 88 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.06762846 |
| 89 | sensory perception of smell (GO:0007608) | 3.05740688 |
| 90 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.04809677 |
| 91 | regulation of podosome assembly (GO:0071801) | 3.04700452 |
| 92 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.04469373 |
| 93 | defense response to fungus (GO:0050832) | 3.02746135 |
| 94 | cyclooxygenase pathway (GO:0019371) | 3.01844353 |
| 95 | mucosal immune response (GO:0002385) | 3.00295363 |
| 96 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.99120878 |
| 97 | intestinal absorption (GO:0050892) | 2.96045815 |
| 98 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.94356326 |
| 99 | regulation of cholesterol storage (GO:0010885) | 2.93427084 |
| 100 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.92813447 |
| 101 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.92458994 |
| 102 | positive regulation of cholesterol efflux (GO:0010875) | 2.90559468 |
| 103 | ethanol metabolic process (GO:0006067) | 2.87821483 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 2.87400863 |
| 105 | thrombin receptor signaling pathway (GO:0070493) | 2.86658431 |
| 106 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.85376516 |
| 107 | * tight junction assembly (GO:0070830) | 2.85374820 |
| 108 | positive regulation of actin filament depolymerization (GO:0030836) | 2.85312425 |
| 109 | copper ion transport (GO:0006825) | 2.82866111 |
| 110 | organ or tissue specific immune response (GO:0002251) | 2.81613348 |
| 111 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.80413843 |
| 112 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.75023104 |
| 113 | regulation of macrophage chemotaxis (GO:0010758) | 2.74839779 |
| 114 | glutathione biosynthetic process (GO:0006750) | 2.73644761 |
| 115 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.73592839 |
| 116 | beta-amyloid metabolic process (GO:0050435) | 2.71056270 |
| 117 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.69617235 |
| 118 | epithelial structure maintenance (GO:0010669) | 2.68693221 |
| 119 | response to peptidoglycan (GO:0032494) | 2.67675011 |
| 120 | renal system process involved in regulation of blood volume (GO:0001977) | 2.67549906 |
| 121 | flavonoid metabolic process (GO:0009812) | 2.67101876 |
| 122 | positive regulation of sterol transport (GO:0032373) | 2.66171977 |
| 123 | positive regulation of cholesterol transport (GO:0032376) | 2.66171977 |
| 124 | primary alcohol catabolic process (GO:0034310) | 2.65823729 |
| 125 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.65503472 |
| 126 | cardiac conduction (GO:0061337) | 2.63880522 |
| 127 | ganglion development (GO:0061548) | 2.63685578 |
| 128 | molting cycle (GO:0042303) | 2.63331822 |
| 129 | hair cycle (GO:0042633) | 2.63331822 |
| 130 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.62284073 |
| 131 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.60747395 |
| 132 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60626306 |
| 133 | response to thyroid hormone (GO:0097066) | 2.58945632 |
| 134 | amino sugar catabolic process (GO:0046348) | 2.57286450 |
| 135 | cellular glucuronidation (GO:0052695) | 2.57217482 |
| 136 | fructose metabolic process (GO:0006000) | 2.56949719 |
| 137 | protein localization to endosome (GO:0036010) | 2.55925273 |
| 138 | monocyte chemotaxis (GO:0002548) | 2.55236325 |
| 139 | intestinal cholesterol absorption (GO:0030299) | 2.54465380 |
| 140 | vitamin D metabolic process (GO:0042359) | 2.53484149 |
| 141 | uronic acid metabolic process (GO:0006063) | 2.52081410 |
| 142 | cellular response to cadmium ion (GO:0071276) | 2.51763479 |
| 143 | innate immune response in mucosa (GO:0002227) | 2.51327234 |
| 144 | sulfate transmembrane transport (GO:1902358) | 2.50457231 |
| 145 | positive regulation of extracellular matrix organization (GO:1903055) | 2.50198988 |
| 146 | regulation of cholesterol efflux (GO:0010874) | 2.49547798 |
| 147 | adipose tissue development (GO:0060612) | 2.49148927 |
| 148 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.48514225 |
| 149 | glucuronate metabolic process (GO:0019585) | 2.48249079 |
| 150 | macrophage activation involved in immune response (GO:0002281) | 2.47692628 |
| 151 | NIK/NF-kappaB signaling (GO:0038061) | 2.47571420 |
| 152 | negative regulation of interleukin-12 production (GO:0032695) | 2.47320026 |
| 153 | regulation of chemokine biosynthetic process (GO:0045073) | 2.47229499 |
| 154 | apoptotic cell clearance (GO:0043277) | 2.46563783 |
| 155 | sphingomyelin metabolic process (GO:0006684) | 2.44905140 |
| 156 | positive regulation of tissue remodeling (GO:0034105) | 2.44073128 |
| 157 | immunoglobulin mediated immune response (GO:0016064) | 2.42462077 |
| 158 | bile acid and bile salt transport (GO:0015721) | 2.40947937 |
| 159 | epithelial cell-cell adhesion (GO:0090136) | 2.40514166 |
| 160 | glycoside metabolic process (GO:0016137) | 2.36060598 |
| 161 | regulation of cholesterol esterification (GO:0010872) | 2.34929259 |
| 162 | regulation of intracellular pH (GO:0051453) | 2.34345669 |
| 163 | decidualization (GO:0046697) | 2.33581482 |
| 164 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.33434490 |
| 165 | urea cycle (GO:0000050) | 2.33380075 |
| 166 | keratan sulfate catabolic process (GO:0042340) | 2.32588368 |
| 167 | urea metabolic process (GO:0019627) | 2.32031553 |
| 168 | glycosylceramide metabolic process (GO:0006677) | 2.31576978 |
| 169 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.31530757 |
| 170 | type I interferon signaling pathway (GO:0060337) | 2.29826413 |
| 171 | cellular response to type I interferon (GO:0071357) | 2.29826413 |
| 172 | T-helper 1 type immune response (GO:0042088) | 2.29400474 |
| 173 | regulation of cellular extravasation (GO:0002691) | 2.29345360 |
| 174 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.28731913 |
| 175 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.28731913 |
| 176 | response to laminar fluid shear stress (GO:0034616) | 2.27532337 |
| 177 | neutrophil activation involved in immune response (GO:0002283) | 2.27253366 |
| 178 | response to type I interferon (GO:0034340) | 2.27125175 |
| 179 | positive regulation of leukocyte degranulation (GO:0043302) | 2.26665393 |
| 180 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.25967163 |
| 181 | response to acidic pH (GO:0010447) | 2.23945230 |
| 182 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.23925136 |
| 183 | regulation of cellular pH (GO:0030641) | 2.22856887 |
| 184 | positive regulation of heat generation (GO:0031652) | 2.21390418 |
| 185 | oligosaccharide biosynthetic process (GO:0009312) | 2.20496347 |
| 186 | NADH metabolic process (GO:0006734) | 2.20397250 |
| 187 | establishment of skin barrier (GO:0061436) | 10.7396899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.54570216 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.30663215 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.42757168 |
| 4 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.11705502 |
| 5 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.96650499 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.91555759 |
| 7 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.91085852 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.88116266 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.68583322 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.62342412 |
| 11 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.61876366 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.54968372 |
| 13 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.51831726 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47664472 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.36292596 |
| 16 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.36277495 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.32826044 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31267464 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.29856421 |
| 20 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.29772303 |
| 21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.20826132 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.18196385 |
| 23 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.17830716 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15062657 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10472323 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.06413024 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.03019709 |
| 28 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.02371875 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.99957761 |
| 30 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.95099126 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.92111921 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87299821 |
| 33 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.81202616 |
| 34 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.80508170 |
| 35 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79364062 |
| 36 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.77522975 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71894135 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.71767477 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63951936 |
| 40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.59705194 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58478531 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57251747 |
| 43 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.56506195 |
| 44 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55659962 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53097041 |
| 46 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.51835337 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.51835337 |
| 48 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.51477731 |
| 49 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.46737972 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42752408 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42388285 |
| 52 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41358243 |
| 53 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.41193001 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39484611 |
| 55 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.39303729 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39281245 |
| 57 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38538773 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36749565 |
| 59 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34914149 |
| 60 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32723305 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30614148 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29207761 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28548872 |
| 64 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27506657 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27109555 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26877157 |
| 67 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26773795 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23762671 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23710266 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23613887 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22042903 |
| 72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21739818 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19399074 |
| 74 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17926452 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17873104 |
| 76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16485264 |
| 77 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.15692644 |
| 78 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15199912 |
| 79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12597926 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12142139 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12109090 |
| 82 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.12032716 |
| 83 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10426005 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10049412 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08850742 |
| 86 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.08780945 |
| 87 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08378259 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07489936 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06935341 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05862353 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05606361 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04049363 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03909564 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03772004 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02693911 |
| 96 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.02521081 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01915077 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01173191 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00950042 |
| 100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00399512 |
| 101 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00152428 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99698871 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97320658 |
| 104 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97115992 |
| 105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96496343 |
| 106 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96346980 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95578181 |
| 108 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.95365234 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94386799 |
| 110 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94187894 |
| 111 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.94118527 |
| 112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93938203 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93258627 |
| 114 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92976469 |
| 115 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92685479 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91107773 |
| 117 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90452206 |
| 118 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89991080 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89979550 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89377013 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89343094 |
| 122 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89217344 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88877651 |
| 124 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88762856 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88684775 |
| 126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88198776 |
| 127 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.87558615 |
| 128 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.87558615 |
| 129 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.87238345 |
| 130 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86961878 |
| 131 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.86111839 |
| 132 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86027593 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85452639 |
| 134 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85076500 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83464608 |
| 136 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83006073 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82541608 |
| 138 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80851361 |
| 139 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77844407 |
| 140 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76192475 |
| 141 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.76060733 |
| 142 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.75649623 |
| 143 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.75039972 |
| 144 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.73779884 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.73282999 |
| 146 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72067631 |
| 147 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71895765 |
| 148 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71601017 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70443125 |
| 150 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.69672803 |
| 151 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.69291248 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.69175667 |
| 153 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.68883955 |
| 154 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.68802477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.01777377 |
| 2 | MP0002796_impaired_skin_barrier | 6.43661103 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.37619862 |
| 4 | MP0003941_abnormal_skin_development | 4.59255184 |
| 5 | MP0005451_abnormal_body_composition | 4.00987927 |
| 6 | MP0005275_abnormal_skin_tensile | 3.97105092 |
| 7 | MP0009840_abnormal_foam_cell | 3.81091544 |
| 8 | MP0005501_abnormal_skin_physiology | 3.61864925 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.35267544 |
| 10 | MP0003878_abnormal_ear_physiology | 3.32495695 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 3.32495695 |
| 12 | MP0003303_peritoneal_inflammation | 3.09794756 |
| 13 | MP0008789_abnormal_olfactory_epithelium | 2.82325814 |
| 14 | MP0002060_abnormal_skin_morphology | 2.79734595 |
| 15 | MP0005365_abnormal_bile_salt | 2.69687033 |
| 16 | MP0006082_CNS_inflammation | 2.61606893 |
| 17 | MP0005499_abnormal_olfactory_system | 2.49113555 |
| 18 | MP0005394_taste/olfaction_phenotype | 2.49113555 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.48399935 |
| 20 | MP0002009_preneoplasia | 2.48025065 |
| 21 | MP0004381_abnormal_hair_follicle | 2.39841527 |
| 22 | MP0001216_abnormal_epidermal_layer | 2.27458203 |
| 23 | MP0003724_increased_susceptibility_to | 2.26879307 |
| 24 | MP0010678_abnormal_skin_adnexa | 2.18178127 |
| 25 | MP0010771_integument_phenotype | 2.15618717 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.15423136 |
| 27 | MP0009785_altered_susceptibility_to | 2.15422818 |
| 28 | MP0001984_abnormal_olfaction | 2.09581607 |
| 29 | MP0004947_skin_inflammation | 2.06706402 |
| 30 | MP0002098_abnormal_vibrissa_morphology | 2.00338305 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.96524438 |
| 32 | MP0000647_abnormal_sebaceous_gland | 1.96207789 |
| 33 | MP0003436_decreased_susceptibility_to | 1.92697876 |
| 34 | MP0004782_abnormal_surfactant_physiolog | 1.87532121 |
| 35 | MP0000604_amyloidosis | 1.86859808 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.83580488 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.81514945 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.72267087 |
| 39 | MP0000343_altered_response_to | 1.63335451 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.61034081 |
| 41 | MP0002419_abnormal_innate_immunity | 1.60986029 |
| 42 | MP0005387_immune_system_phenotype | 1.58141001 |
| 43 | MP0001790_abnormal_immune_system | 1.58141001 |
| 44 | MP0005025_abnormal_response_to | 1.56981888 |
| 45 | MP0000377_abnormal_hair_follicle | 1.56401087 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.55846227 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.55700869 |
| 48 | MP0005166_decreased_susceptibility_to | 1.53624430 |
| 49 | MP0003075_altered_response_to | 1.51207767 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.50865400 |
| 51 | MP0004510_myositis | 1.50826361 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.50377525 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.50144782 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.50100931 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.48457521 |
| 56 | MP0000427_abnormal_hair_cycle | 1.46583876 |
| 57 | MP0009764_decreased_sensitivity_to | 1.41660427 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.38073743 |
| 59 | MP0005310_abnormal_salivary_gland | 1.31613712 |
| 60 | MP0001666_abnormal_nutrient_absorption | 1.26996972 |
| 61 | MP0005165_increased_susceptibility_to | 1.26092467 |
| 62 | MP0000537_abnormal_urethra_morphology | 1.25791496 |
| 63 | MP0001873_stomach_inflammation | 1.25430296 |
| 64 | MP0000462_abnormal_digestive_system | 1.24946313 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.24065513 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.23128446 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.22611913 |
| 68 | MP0008469_abnormal_protein_level | 1.19328511 |
| 69 | MP0000762_abnormal_tongue_morphology | 1.18367996 |
| 70 | MP0002254_reproductive_system_inflammat | 1.18056069 |
| 71 | MP0003879_abnormal_hair_cell | 1.17046730 |
| 72 | MP0000858_altered_metastatic_potential | 1.16593867 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.15990365 |
| 74 | MP0009931_abnormal_skin_appearance | 1.13997307 |
| 75 | MP0003448_altered_tumor_morphology | 1.12680026 |
| 76 | MP0002233_abnormal_nose_morphology | 1.11108793 |
| 77 | MP0005023_abnormal_wound_healing | 1.10590947 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.09114421 |
| 79 | MP0003329_amyloid_beta_deposits | 1.06032577 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.03439196 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.03368708 |
| 82 | MP0004742_abnormal_vestibular_system | 1.03265845 |
| 83 | MP0003866_abnormal_defecation | 1.02472912 |
| 84 | MP0003868_abnormal_feces_composition | 0.98222911 |
| 85 | MP0000467_abnormal_esophagus_morphology | 0.98176208 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.98025286 |
| 87 | MP0001191_abnormal_skin_condition | 0.97365974 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.96736336 |
| 89 | MP0005360_urolithiasis | 0.96546388 |
| 90 | MP0005164_abnormal_response_to | 0.94643647 |
| 91 | MP0000579_abnormal_nail_morphology | 0.93811889 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.93417558 |
| 93 | MP0000516_abnormal_urinary_system | 0.93417558 |
| 94 | MP0001849_ear_inflammation | 0.93359381 |
| 95 | MP0000003_abnormal_adipose_tissue | 0.93182143 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.92845823 |
| 97 | MP0002723_abnormal_immune_serum | 0.92078448 |
| 98 | MP0005187_abnormal_penis_morphology | 0.91312475 |
| 99 | MP0000609_abnormal_liver_physiology | 0.90964852 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.90891957 |
| 101 | MP0001853_heart_inflammation | 0.90414592 |
| 102 | MP0000685_abnormal_immune_system | 0.90383763 |
| 103 | MP0003690_abnormal_glial_cell | 0.89793276 |
| 104 | MP0005671_abnormal_response_to | 0.86693065 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.85672085 |
| 106 | MP0001800_abnormal_humoral_immune | 0.85653019 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.84258662 |
| 108 | MP0008004_abnormal_stomach_pH | 0.83554408 |
| 109 | MP0009278_abnormal_bone_marrow | 0.83459738 |
| 110 | MP0004885_abnormal_endolymph | 0.81784307 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.81705697 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.81197442 |
| 113 | MP0000566_synostosis | 0.81068761 |
| 114 | MP0003091_abnormal_cell_migration | 0.81027548 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.79854035 |
| 116 | MP0000477_abnormal_intestine_morphology | 0.79696812 |
| 117 | MP0000490_abnormal_crypts_of | 0.79577109 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.79076724 |
| 119 | MP0000613_abnormal_salivary_gland | 0.78781964 |
| 120 | MP0005390_skeleton_phenotype | 0.78605636 |
| 121 | MP0005670_abnormal_white_adipose | 0.78154475 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.77794364 |
| 123 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77714604 |
| 124 | MP0003252_abnormal_bile_duct | 0.77571939 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.76215902 |
| 126 | MP0005085_abnormal_gallbladder_physiolo | 0.76214932 |
| 127 | MP0000026_abnormal_inner_ear | 0.75507887 |
| 128 | MP0001819_abnormal_immune_cell | 0.75382962 |
| 129 | MP0003195_calcinosis | 0.75248941 |
| 130 | MP0002420_abnormal_adaptive_immunity | 0.74531792 |
| 131 | MP0000383_abnormal_hair_follicle | 0.73405656 |
| 132 | MP0003315_abnormal_perineum_morphology | 0.73255529 |
| 133 | MP0000049_abnormal_middle_ear | 0.73114212 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.73102419 |
| 135 | MP0002132_abnormal_respiratory_system | 0.72826908 |
| 136 | MP0003795_abnormal_bone_structure | 0.72673966 |
| 137 | MP0005332_abnormal_amino_acid | 0.72186543 |
| 138 | MP0006072_abnormal_retinal_apoptosis | 0.68570441 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.68310061 |
| 140 | MP0001542_abnormal_bone_strength | 0.67884741 |
| 141 | MP0001663_abnormal_digestive_system | 0.67831087 |
| 142 | MP0010386_abnormal_urinary_bladder | 0.67623309 |
| 143 | MP0002249_abnormal_larynx_morphology | 0.67397164 |
| 144 | MP0001243_abnormal_dermal_layer | 0.67376936 |
| 145 | MP0001963_abnormal_hearing_physiology | 0.66848949 |
| 146 | MP0001664_abnormal_digestion | 0.66675725 |
| 147 | MP0000470_abnormal_stomach_morphology | 0.65534197 |
| 148 | MP0006054_spinal_hemorrhage | 0.65412817 |
| 149 | MP0000367_abnormal_coat/_hair | 0.65130546 |
| 150 | MP0001944_abnormal_pancreas_morphology | 0.64854697 |
| 151 | MP0005375_adipose_tissue_phenotype | 0.64502930 |
| 152 | MP0004043_abnormal_pH_regulation | 0.64449814 |
| 153 | MP0004019_abnormal_vitamin_homeostasis | 0.63039676 |
| 154 | MP0005248_abnormal_Harderian_gland | 0.62715448 |
| 155 | MP0000538_abnormal_urinary_bladder | 0.62713595 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.62376808 |
| 157 | MP0001177_atelectasis | 0.60304605 |
| 158 | MP0002138_abnormal_hepatobiliary_system | 0.60105993 |
| 159 | MP0000013_abnormal_adipose_tissue | 0.59818727 |
| 160 | MP0010352_gastrointestinal_tract_polyps | 0.58112809 |
| 161 | MP0002166_altered_tumor_susceptibility | 0.57771154 |
| 162 | MP0003787_abnormal_imprinting | 0.55306270 |
| 163 | MP0005076_abnormal_cell_differentiation | 0.54781319 |
| 164 | MP0005220_abnormal_exocrine_pancreas | 0.54690047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 6.77957872 |
| 2 | Congenital ichthyosiform erythroderma (HP:0007431) | 6.67953649 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.29808224 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.29808224 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.29808224 |
| 6 | Increased IgE level (HP:0003212) | 6.08739996 |
| 7 | Onycholysis (HP:0001806) | 5.72768584 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.03853068 |
| 9 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.02271599 |
| 10 | Lip pit (HP:0100267) | 4.58337907 |
| 11 | Curly hair (HP:0002212) | 4.44943222 |
| 12 | Pustule (HP:0200039) | 4.25605408 |
| 13 | Woolly hair (HP:0002224) | 4.15486621 |
| 14 | Hypotrichosis (HP:0001006) | 4.12124914 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.02002678 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.76439786 |
| 17 | Thin bony cortex (HP:0002753) | 3.75412346 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.66349428 |
| 19 | Widely patent fontanelles and sutures (HP:0004492) | 3.61443914 |
| 20 | Abnormality of nail color (HP:0100643) | 3.60035949 |
| 21 | Plantar hyperkeratosis (HP:0007556) | 3.59319828 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.53335068 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.53335068 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.53335068 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.53285122 |
| 26 | Chronic bronchitis (HP:0004469) | 3.52460397 |
| 27 | Corneal erosion (HP:0200020) | 3.51693241 |
| 28 | Loss of speech (HP:0002371) | 3.51500481 |
| 29 | Dehydration (HP:0001944) | 3.48678855 |
| 30 | Malnutrition (HP:0004395) | 3.47889690 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.45591017 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.45591017 |
| 33 | Abnormality of the gastric mucosa (HP:0004295) | 3.44279885 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.38237624 |
| 35 | Enlarged epiphyses (HP:0010580) | 3.35829311 |
| 36 | Fragile nails (HP:0001808) | 3.33598368 |
| 37 | Ectropion (HP:0000656) | 3.32167950 |
| 38 | Gangrene (HP:0100758) | 3.27808316 |
| 39 | Decreased circulating renin level (HP:0003351) | 3.15282829 |
| 40 | Erythroderma (HP:0001019) | 3.07362181 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04403567 |
| 42 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.02927080 |
| 43 | Glomerulonephritis (HP:0000099) | 3.01878294 |
| 44 | Delayed epiphyseal ossification (HP:0002663) | 3.01269222 |
| 45 | Complement deficiency (HP:0004431) | 3.01060824 |
| 46 | Palmoplantar hyperkeratosis (HP:0000972) | 2.95839216 |
| 47 | Abnormality of chloride homeostasis (HP:0011422) | 2.95224385 |
| 48 | Xanthomatosis (HP:0000991) | 2.93196293 |
| 49 | Pruritus (HP:0000989) | 2.91881688 |
| 50 | Hydroxyprolinuria (HP:0003080) | 2.89967608 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.89967608 |
| 52 | Intrahepatic cholestasis (HP:0001406) | 2.85830883 |
| 53 | Parakeratosis (HP:0001036) | 2.81949805 |
| 54 | Disinhibition (HP:0000734) | 2.81703224 |
| 55 | Abnormality of complement system (HP:0005339) | 2.77806509 |
| 56 | Palpitations (HP:0001962) | 2.77391312 |
| 57 | Palmar hyperkeratosis (HP:0010765) | 2.75500786 |
| 58 | Axonal loss (HP:0003447) | 2.74470184 |
| 59 | Hypohidrosis (HP:0000966) | 2.72887451 |
| 60 | Myocardial infarction (HP:0001658) | 2.72714558 |
| 61 | Villous atrophy (HP:0011473) | 2.70439740 |
| 62 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.70439740 |
| 63 | Ileus (HP:0002595) | 2.68142521 |
| 64 | Syncope (HP:0001279) | 2.67140211 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 2.65284241 |
| 66 | Alopecia of scalp (HP:0002293) | 2.63382829 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.61427967 |
| 68 | Potter facies (HP:0002009) | 2.57737162 |
| 69 | Facial shape deformation (HP:0011334) | 2.57737162 |
| 70 | Flat acetabular roof (HP:0003180) | 2.57645504 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.57058727 |
| 72 | Abnormality of the costochondral junction (HP:0000919) | 2.56484237 |
| 73 | Nuclear cataract (HP:0100018) | 2.56478806 |
| 74 | Recurrent abscess formation (HP:0002722) | 2.52630249 |
| 75 | Hyperactive renin-angiotensin system (HP:0000841) | 2.51269550 |
| 76 | Fat malabsorption (HP:0002630) | 2.47878230 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.47405911 |
| 78 | Ventricular tachycardia (HP:0004756) | 2.44511689 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44447323 |
| 80 | Progressive hearing impairment (HP:0001730) | 2.42337038 |
| 81 | Acanthosis nigricans (HP:0000956) | 2.40538307 |
| 82 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.37205846 |
| 83 | Abdominal distention (HP:0003270) | 2.32241799 |
| 84 | Eczematoid dermatitis (HP:0000976) | 2.30875463 |
| 85 | Metaphyseal irregularity (HP:0003025) | 2.29455437 |
| 86 | Popliteal pterygium (HP:0009756) | 2.28905090 |
| 87 | Bone pain (HP:0002653) | 2.27163372 |
| 88 | Milia (HP:0001056) | 2.23674623 |
| 89 | Protuberant abdomen (HP:0001538) | 2.23326975 |
| 90 | Rectal prolapse (HP:0002035) | 2.22786916 |
| 91 | Amyloidosis (HP:0011034) | 2.21406524 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 2.18196243 |
| 93 | Wide cranial sutures (HP:0010537) | 2.18115359 |
| 94 | Hypothermia (HP:0002045) | 2.18091056 |
| 95 | Prolonged neonatal jaundice (HP:0006579) | 2.17807070 |
| 96 | Mutism (HP:0002300) | 2.17096549 |
| 97 | Metabolic alkalosis (HP:0200114) | 2.16669026 |
| 98 | Vertebral compression fractures (HP:0002953) | 2.16501865 |
| 99 | Cheilitis (HP:0100825) | 2.15967724 |
| 100 | Ventricular fibrillation (HP:0001663) | 2.15633014 |
| 101 | Pili torti (HP:0003777) | 2.15114190 |
| 102 | Rickets (HP:0002748) | 2.14378607 |
| 103 | Palmoplantar keratoderma (HP:0000982) | 2.14155393 |
| 104 | Hemorrhage of the eye (HP:0011885) | 2.12590345 |
| 105 | Nasal polyposis (HP:0100582) | 2.10701169 |
| 106 | Erythema (HP:0010783) | 2.10657236 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 2.10200700 |
| 108 | Hyperparathyroidism (HP:0000843) | 2.08398526 |
| 109 | Petechiae (HP:0000967) | 2.08203692 |
| 110 | Conjunctival hamartoma (HP:0100780) | 2.07477598 |
| 111 | Increased serum ferritin (HP:0003281) | 2.07132137 |
| 112 | Nephritis (HP:0000123) | 2.06499995 |
| 113 | Abnormality of renin-angiotensin system (HP:0000847) | 2.06494001 |
| 114 | Abnormal blistering of the skin (HP:0008066) | 2.05041660 |
| 115 | Steatorrhea (HP:0002570) | 2.05008903 |
| 116 | Hematochezia (HP:0002573) | 2.03112479 |
| 117 | Asthma (HP:0002099) | 2.02573001 |
| 118 | Oligodontia (HP:0000677) | 2.02499572 |
| 119 | Hyporeflexia of lower limbs (HP:0002600) | 2.02412493 |
| 120 | Abnormality of macular pigmentation (HP:0008002) | 2.01297819 |
| 121 | Purpura (HP:0000979) | 2.01158132 |
| 122 | Progressive neurologic deterioration (HP:0002344) | 2.00793772 |
| 123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.99994465 |
| 124 | Hypoplasia of dental enamel (HP:0006297) | 1.99524187 |
| 125 | Dry skin (HP:0000958) | 1.98706658 |
| 126 | Skin nodule (HP:0200036) | 1.98683983 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.97562392 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97562392 |
| 129 | Alkalosis (HP:0001948) | 1.96183251 |
| 130 | Exocrine pancreatic insufficiency (HP:0001738) | 1.96069690 |
| 131 | Anhidrosis (HP:0000970) | 1.94985355 |
| 132 | Abnormal tarsal ossification (HP:0008369) | 1.93662701 |
| 133 | Hypoplasia of the uterus (HP:0000013) | 1.93613172 |
| 134 | Cardiomegaly (HP:0001640) | 1.93035490 |
| 135 | Atrophic scars (HP:0001075) | 1.92484516 |
| 136 | Orchitis (HP:0100796) | 1.91748071 |
| 137 | Azoospermia (HP:0000027) | 1.91575375 |
| 138 | Vascular calcification (HP:0004934) | 1.91240420 |
| 139 | Nausea (HP:0002018) | 1.90829998 |
| 140 | Asymmetric septal hypertrophy (HP:0001670) | 1.90763839 |
| 141 | Abnormal pancreas size (HP:0012094) | 1.90066870 |
| 142 | Concave nail (HP:0001598) | 1.89753752 |
| 143 | Hypokalemia (HP:0002900) | 1.89120971 |
| 144 | Hypoplastic labia majora (HP:0000059) | 1.88679664 |
| 145 | Multiple lipomas (HP:0001012) | 1.88117373 |
| 146 | Unilateral renal agenesis (HP:0000122) | 1.87932956 |
| 147 | Tetraparesis (HP:0002273) | 1.87516333 |
| 148 | Interstitial pulmonary disease (HP:0006530) | 1.86426175 |
| 149 | Xerostomia (HP:0000217) | 1.85167715 |
| 150 | Advanced eruption of teeth (HP:0006288) | 1.84346379 |
| 151 | Hyperaldosteronism (HP:0000859) | 1.84318786 |
| 152 | Absent eyebrow (HP:0002223) | 1.82820393 |
| 153 | Hepatosplenomegaly (HP:0001433) | 1.82535436 |
| 154 | Cerebral inclusion bodies (HP:0100314) | 1.82413739 |
| 155 | Increased CSF protein (HP:0002922) | 1.82235316 |
| 156 | Ovoid vertebral bodies (HP:0003300) | 1.81394117 |
| 157 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.81003876 |
| 158 | Thoracic kyphosis (HP:0002942) | 1.79613809 |
| 159 | Conjugated hyperbilirubinemia (HP:0002908) | 1.78132261 |
| 160 | Asymmetry of the thorax (HP:0001555) | 1.77917793 |
| 161 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.77263351 |
| 162 | Vacuolated lymphocytes (HP:0001922) | 1.76470015 |
| 163 | Apathy (HP:0000741) | 1.75825857 |
| 164 | Abnormality of the right ventricle (HP:0001707) | 1.75240649 |
| 165 | Abnormality of cochlea (HP:0000375) | 1.73271537 |
| 166 | Hypophosphatemia (HP:0002148) | 1.72934055 |
| 167 | Sparse scalp hair (HP:0002209) | 1.72630692 |
| 168 | Hypotension (HP:0002615) | 1.72582524 |
| 169 | Abnormality of the 1st metacarpal (HP:0010009) | 1.72458070 |
| 170 | Gingivitis (HP:0000230) | 1.72254828 |
| 171 | Diminished motivation (HP:0000745) | 1.72179839 |
| 172 | Abnormality of placental membranes (HP:0011409) | 1.72080787 |
| 173 | Amniotic constriction ring (HP:0009775) | 1.72080787 |
| 174 | Sparse eyelashes (HP:0000653) | 1.71746392 |
| 175 | Severe Myopia (HP:0011003) | 1.71078152 |
| 176 | Septate vagina (HP:0001153) | 1.70646206 |
| 177 | Abnormality of the lumbar spine (HP:0100712) | 1.70526318 |
| 178 | Bone cyst (HP:0012062) | 1.70425804 |
| 179 | Premature loss of primary teeth (HP:0006323) | 1.70068992 |
| 180 | Short nail (HP:0001799) | 1.68169178 |
| 181 | Cervical subluxation (HP:0003308) | 1.66007183 |
| 182 | Pathologic fracture (HP:0002756) | 1.65755628 |
| 183 | Abnormality of iron homeostasis (HP:0011031) | 1.65311976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPKAPK3 | 5.10945312 |
| 2 | MST4 | 4.21913538 |
| 3 | FRK | 3.82861350 |
| 4 | IRAK3 | 3.64740870 |
| 5 | ERBB3 | 3.29121530 |
| 6 | EEF2K | 3.21691480 |
| 7 | MST1R | 3.03645378 |
| 8 | LMTK2 | 2.92246910 |
| 9 | NME2 | 2.90652388 |
| 10 | RPS6KB2 | 2.90637961 |
| 11 | ACVR1B | 2.86618942 |
| 12 | EPHA2 | 2.83303539 |
| 13 | MAP3K2 | 2.76848798 |
| 14 | MAPKAPK5 | 2.41936457 |
| 15 | TRPM7 | 2.30634698 |
| 16 | TESK1 | 2.28657930 |
| 17 | STK24 | 2.07218279 |
| 18 | GRK7 | 2.04520714 |
| 19 | MAPK15 | 2.00106379 |
| 20 | BMPR2 | 1.93784066 |
| 21 | TYK2 | 1.91945371 |
| 22 | FER | 1.91193853 |
| 23 | MAP2K2 | 1.79119624 |
| 24 | PTK6 | 1.65708310 |
| 25 | ABL2 | 1.64457926 |
| 26 | DDR2 | 1.59065432 |
| 27 | EPHB2 | 1.55737456 |
| 28 | TAOK2 | 1.54455751 |
| 29 | PAK4 | 1.52167201 |
| 30 | TGFBR2 | 1.52164856 |
| 31 | INSRR | 1.45565909 |
| 32 | NUAK1 | 1.43826498 |
| 33 | TAOK1 | 1.41755515 |
| 34 | PRKG2 | 1.39142120 |
| 35 | CDC42BPA | 1.31676652 |
| 36 | DYRK1B | 1.31207464 |
| 37 | RIPK4 | 1.23302721 |
| 38 | CDK3 | 1.21472765 |
| 39 | CSK | 1.19674274 |
| 40 | AKT3 | 1.15864355 |
| 41 | MAP2K1 | 1.12125047 |
| 42 | MAP3K12 | 1.09868992 |
| 43 | FGR | 1.08624752 |
| 44 | PIK3CA | 1.08527000 |
| 45 | GRK1 | 1.07924025 |
| 46 | IKBKB | 1.06149151 |
| 47 | RIPK1 | 1.06117854 |
| 48 | SMG1 | 1.05242306 |
| 49 | PAK3 | 1.04864132 |
| 50 | TESK2 | 1.04246271 |
| 51 | IRAK1 | 1.02567223 |
| 52 | STK38L | 1.01409887 |
| 53 | MAP3K3 | 1.00341101 |
| 54 | PDK2 | 0.99892375 |
| 55 | PDGFRA | 0.98635280 |
| 56 | IRAK4 | 0.97038161 |
| 57 | NEK1 | 0.96657164 |
| 58 | NME1 | 0.96261151 |
| 59 | ZAP70 | 0.95348404 |
| 60 | LATS1 | 0.95320047 |
| 61 | MAPK13 | 0.94631866 |
| 62 | ERBB2 | 0.90746114 |
| 63 | ADRBK2 | 0.90015251 |
| 64 | CAMK2D | 0.89166081 |
| 65 | FGFR4 | 0.88764185 |
| 66 | LIMK1 | 0.87833847 |
| 67 | PIK3CG | 0.87612562 |
| 68 | SIK1 | 0.85340768 |
| 69 | BCR | 0.81505977 |
| 70 | SRPK1 | 0.79313217 |
| 71 | PDPK1 | 0.76643938 |
| 72 | JAK1 | 0.76478847 |
| 73 | PRKCI | 0.76363392 |
| 74 | HIPK2 | 0.74777789 |
| 75 | STK16 | 0.73683737 |
| 76 | MAP3K10 | 0.73516284 |
| 77 | ERN1 | 0.73292949 |
| 78 | PRKAA2 | 0.73208436 |
| 79 | DYRK3 | 0.72028733 |
| 80 | LATS2 | 0.69961349 |
| 81 | MAPKAPK2 | 0.69513121 |
| 82 | MAP3K7 | 0.64739897 |
| 83 | MAP3K9 | 0.63186905 |
| 84 | RPS6KA2 | 0.63073376 |
| 85 | PRKD3 | 0.62063777 |
| 86 | ICK | 0.60894524 |
| 87 | MAP2K3 | 0.60847930 |
| 88 | MAP3K1 | 0.59358638 |
| 89 | IKBKE | 0.58758331 |
| 90 | TRIB3 | 0.58635527 |
| 91 | MOS | 0.58497518 |
| 92 | IRAK2 | 0.57753385 |
| 93 | DAPK2 | 0.57490541 |
| 94 | PBK | 0.56573366 |
| 95 | EPHB1 | 0.56158433 |
| 96 | JAK3 | 0.55073304 |
| 97 | CSNK1A1L | 0.54951081 |
| 98 | CDK6 | 0.54082348 |
| 99 | ERBB4 | 0.54036351 |
| 100 | MAP3K14 | 0.53091846 |
| 101 | DMPK | 0.50794960 |
| 102 | CHUK | 0.50014369 |
| 103 | WNK1 | 0.49164683 |
| 104 | BLK | 0.48516492 |
| 105 | PRPF4B | 0.47985097 |
| 106 | MAP4K1 | 0.47746659 |
| 107 | WNK4 | 0.47472873 |
| 108 | NEK9 | 0.44178862 |
| 109 | CAMK2B | 0.42538361 |
| 110 | MYLK | 0.42453622 |
| 111 | MAP2K6 | 0.41023333 |
| 112 | BMX | 0.40562016 |
| 113 | PIM2 | 0.39773546 |
| 114 | YES1 | 0.39766848 |
| 115 | CSF1R | 0.39247302 |
| 116 | MAPK11 | 0.38403880 |
| 117 | MAP3K8 | 0.38163746 |
| 118 | MET | 0.38013442 |
| 119 | TBK1 | 0.37949008 |
| 120 | MELK | 0.37910263 |
| 121 | ARAF | 0.37469515 |
| 122 | PRKCE | 0.37192160 |
| 123 | MAP3K6 | 0.36321634 |
| 124 | PHKG2 | 0.36222990 |
| 125 | PHKG1 | 0.36222990 |
| 126 | RPS6KL1 | 0.35418729 |
| 127 | RPS6KC1 | 0.35418729 |
| 128 | STK39 | 0.34826792 |
| 129 | CDK9 | 0.34473624 |
| 130 | LYN | 0.34326563 |
| 131 | CAMKK2 | 0.33156417 |
| 132 | PDK1 | 0.31800723 |
| 133 | PRKCD | 0.31334070 |
| 134 | PDGFRB | 0.30817605 |
| 135 | CASK | 0.28863709 |
| 136 | JAK2 | 0.28846510 |
| 137 | MAP3K13 | 0.28343110 |
| 138 | DYRK2 | 0.28065694 |
| 139 | LRRK2 | 0.27962685 |
| 140 | CAMK2G | 0.27347938 |
| 141 | PTK2 | 0.27133596 |
| 142 | RPS6KA1 | 0.26836292 |
| 143 | EPHA3 | 0.26544727 |
| 144 | FGFR1 | 0.25804215 |
| 145 | MAP3K11 | 0.22708304 |
| 146 | ITK | 0.22620215 |
| 147 | BRAF | 0.21660182 |
| 148 | VRK1 | 0.21304572 |
| 149 | PRKCA | 0.20258715 |
| 150 | TAOK3 | 0.19601176 |
| 151 | STK10 | 0.19590805 |
| 152 | MATK | 0.19373146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.34623317 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.94711260 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.80681328 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.79434296 |
| 5 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.59064612 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.58114412 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.49810445 |
| 8 | Mineral absorption_Homo sapiens_hsa04978 | 2.23614223 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.14089401 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.13300944 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10127740 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08388983 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 2.06034706 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.05107913 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.04935247 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01692812 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.00403015 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.99676813 |
| 19 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.93259444 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.89129333 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.88741232 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72330290 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69890361 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69368087 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67125303 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63108550 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.58259476 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.57775856 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.57215504 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56197094 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55696216 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.55619904 |
| 33 | * Tight junction_Homo sapiens_hsa04530 | 1.46352438 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45531117 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.43453093 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41807810 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38785437 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37971818 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.37607087 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34355151 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.29323461 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27771032 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26427489 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.25605712 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21764710 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.20410659 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20201250 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13281886 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.12909565 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.12134558 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10923781 |
| 52 | Adherens junction_Homo sapiens_hsa04520 | 1.07681311 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.03805328 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03541186 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03459593 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 1.01591028 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00802331 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99830603 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99552573 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97910707 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.97561414 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.97476566 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97098275 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.95739181 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95443020 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95347763 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93893362 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 0.89440889 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89118661 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89014389 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88483300 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87838842 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87714318 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83408579 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82112516 |
| 76 | * Hepatitis C_Homo sapiens_hsa05160 | 0.80128529 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79999019 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78338290 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74771515 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74116195 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.72235121 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71701797 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70802290 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69545990 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69436804 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68079400 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67337010 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67010909 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66915008 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.66860333 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.66283229 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.64890985 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64031143 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63173877 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62658042 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61473968 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61166668 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59629285 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59607523 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56232156 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55554683 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55497575 |
| 103 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54735109 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.54692011 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54236075 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.53519717 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53244289 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53155210 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52378895 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52015342 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51369557 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51159856 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50737787 |
| 114 | Taste transduction_Homo sapiens_hsa04742 | 0.50453269 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49939042 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49372332 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48375769 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48104131 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.47168074 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.46393667 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46176693 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.45945665 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45569836 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44505819 |
| 125 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43676634 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43025495 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42655111 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42218934 |
| 129 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41770289 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.41558431 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40780955 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40320434 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39718699 |
| 134 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.39317432 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39133386 |
| 136 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38492100 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38003556 |
| 138 | Shigellosis_Homo sapiens_hsa05131 | 0.36825585 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36742583 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35830216 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35737956 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35308319 |
| 143 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34115453 |
| 144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34004961 |
| 145 | Salivary secretion_Homo sapiens_hsa04970 | 0.33489361 |
| 146 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32868340 |
| 147 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32578121 |
| 148 | Melanoma_Homo sapiens_hsa05218 | 0.32261941 |
| 149 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31801844 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.31409187 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30960426 |
| 152 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30913562 |
| 153 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28857111 |
| 154 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28165053 |
| 155 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26620390 |
| 156 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26010860 |
| 157 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25584225 |

